Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 11-12, 2004, Pages 817-822

  Lotric Furlan, Stanka ^a   Petrovec, Miroslav ^b   Avsic Zupanc, Tatjana ^b   Strle, Franc ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CREATINE KINASE; LACTATE DEHYDROGENASE;

ADULT; AGE; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BACTERIUM CULTURE; BLOOD ANALYSIS; CHILL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; EHRLICHIOSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; IMMUNOFLUORESCENCE; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MEDICAL ASSESSMENT; MYALGIA; POLYMERASE CHAIN REACTION; PROBABILITY; PROSPECTIVE STUDY; SLOVENIA; SYMPTOM; THROMBOCYTOPENIA; TICK BITE;

ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; BITES AND STINGS; EHRLICHIOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SLOVENIA; TICKS;

EID: 11444260286     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410021171     Document Type: Article

References (34)

1. Dumler JS, Barbet AF, Bekker CP, Dasch GA, Pahner GH, Ray SC, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of 6 new species combinations and designation of Ehrlichia equi and HGE agent as subjective synonyms of Ehrlichia phagocytophilum. Int J Syst Evol Microbiol 2001; 51: 2145-65.
2. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275: 199-205.
3. Petrovec M, Lotric-Furlan S, Avsic-Zupanc T, Strle F, Brouqui P, Dumler S. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997; 35: 1556-9.
4. Weber R, Pusterla N, Loy M, Lutz H. Fever, leukopenia, and thrombocytopenia in a patient with acute Lyme borreliosis were due to human granulocytic ehrlichiosis. Clin Infect Dis 1998; 26: 253-4.
5. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Strle F. Human granulocytic ehrlichiosis in Slovenia. Ann NY Acad Sci 2003; 990: 279-84.
6. Laferl H, Hogrefe W, Kock T, Pichler H. A further case of acute human granulocytic ehrlichiosis in Slovenia. Eur J Clin Microbiol Infect Dis 1999; 18: 385-6.
7. Bjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I. Varying clinical picture and course of human granulocytic ehrlichiosis. 12 Scandinavian cases of the new tick-borne zoonosis are presented. Lakartidningen 1999; 96: 4200-4.
8. van Dobbenburgh A, van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in Western Europe. N Engl J Med 1999; 340: 1214-6.
9. Misic-Majerus U, Bujic N, Madjaric V, Janes-Poje V. First description of the human granulocytic ehrlichiosis in Croatia. Clin Microbiol Infect 2000; 6(Suppl 1): 194-5.
10. Oteo JA, Blanco JR, de Artola V, lbarra V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg Infect Dis 2000; 6: 430-1.
11. Lotric-Furlan S, Avsic-Zupanc T, Petrovec M, Nicholson WL, Sumner JW, Childs JE, Strle F. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol 2001; 8: 899-903.
12. Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis: a clinical case in Scandinavia. Scand J Infect Dis 2001; 33: 73-4.
13. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sulek K. First cases of acute human granulocytic ehrlichiosis in Poland. Eur J Clin Microbiol Infect Dis 2001; 20: 196-8.
14. Arnez M, Petrovec M, Lotric-Furlan S, Avsic-Zupanc T, Strle F. First European paediatric case of human granulocytic ehrlichiosis. J Clin Microbiol 2001; 39: 4591-2.
15. Hulinska D, Votypka J, Plch J, Vicek E, Valesova M, Bojar H, et al. Molecular and microscopic evidence of Ehrlichia spp. and Borrelia burgdorferi sensu lato in patients, animals and ticks in the Czech Republic. New Microbiol 2002; 25: 437-48.
16. Prukk T, Ainsalu K, Laja E, Aigro A. Human granulocytic ehrlichiosis in Estonia. Emerg Infect Dis 2003; 9: 1499-500.
17. Walder G, Falkensammer B, Aigner J, Tiwald G, Dierich MP, Wurz R, Lechleitner P. First documented case of human granulocytic ehrlichiosis in Austria. Wien Klin Wochenschr 2003; 115: 263-6.
18. Remy V, Hansmann Y, De Martino S, Christmann D, Brouqui P. Human anaplasmosis presenting as atypical pneumonitis in France. Clin Infect Dis 2003; 37: 846-8.
19. Ruscia M, Cinco M. Human granulocytic ehrlichiosis in Italy: first report of 2 confirmed cases. Ann NY Acad Sci 2003; 990: 279-84.
20. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000; 31: 554-60.
21. Walker DH and the Task Force on Consensus Approach for Ehrlichiosis. Diagnosing human ehrlichioses: current status and recommendations. ASM News 2000; 66: 287-90.
22. Comer JA, Nicholson WL, Olson JG, Childs JE. Serological testing for human granulocytic ehrlichiosis at a national referral centre. J Clin Microbiol 1999; 37: 558-64.
23. Nicholson WL, Comer JA, Sumner JW, Gingrich-Baker C, Coughlin RT, Magnarelli LA, et al. An indirect immunofluorescence assay using a cell-derived antigen for detection of antibodies to the agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol 1997; 35: 1510-6.
24. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Nicholson WL, Sumner JW, Childs JE, Strle F. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for 4 patients from Slovenia. Clin Infect Dis 1998; 27: 424-8.
25. Warner CK, Dawson JE. Genus- and species-level identification of Ehrlichia species by PCR and sequencing. In: Persing HD, ed. PCR protocols for emerging infectious diseases. American Society for Microbiology Washington; 1996. p. 101-5.
26. Sumner JW, Nicholson WL, Massung RF. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol 1997; 35: 2087-92.
27. Hilton E, DeVoti J, Benach JL, Halluska ML, White DJ, Paxton H, Dumler JS. Seroprevalence and seroconversion for tick-borne disease in a high risk population in the northeast United States. Am J Med 1999; 106: 404-9.
28. Strle F. Human granulocytic ehrlichiosis in Europe. Int J Med Microbiol 2004; 293(Suppl 37): 27-35.
29. Wittesjo B, Bjoersdorff A, Eliasson I, Berglund J. First long-term study of the agent of human granulocytic ehrlichiosis among residents of a tick-endemic Sweden. Eur J Clin Microbiol Infect Dis 2001; 20: 173-8.
30. Bakken JS, Goellner P, Van Etten M, Boyle DZ, Swonger OL, Mattson S, et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis 1998; 27: 1491-6.
31. Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, Jacob J, Frey M, Noto R, et al. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol 2002; 40: 2612-5.
32. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Nicholson WL, Sumner JW, Childs JE, Strle F. Prospective assessment of the aetiology of acute febrile illness after a tick bite in Slovenia. Clin Infect Dis 2001; 33: 503-10.
33. Horowitz HW, Aquero-Rosenfeld ME, McKenna DF, Holmgren D, Hsieh TC, Varde SA, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis 1998; 27: 1314-7.
34. Bakken JS, Aguero-Rosenfeld ME, Tilden RL, Wormser GP, Horowitz HW, Raffalli JT, et al. Serial measurements of haematological counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis 2001; 32: 862-70.